ISO/TS 22859:2022

Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from umbilical cord tissue

Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from umbilical cord tissue

Digital Document2022 edition2022Purchase Options

Referenced standards

ISO 20387:2018ISO 21709:2020ISO 8601-1
Unit Price
USD120.90Save 22%
USD 155.00

PREVIEW

ISO/TS 22859:2022

Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from umbilical cord tissue

Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from umbilical cord tissue

This document specifies requirements for the biobanking of human mesenchymal stromal cells derived from umbilical cord tissue (i.e. Wharton’s jelly), further referred to as hUC-MSCs, including the collection of umbilical cord tissue and associated data, isolation, culture characterization, quality control, cryopreservation, storage, thawing, disposal, distribution and transport.

This document is applicable to all organizations performing biobanking of hUC-MSCs used for research and development.

This document does not apply to hUC-MSCs for the purpose of in vivo application in humans, clinical applications or therapeutic use.

NOTE????? International, national or regional regulations or requirements, or multiple of them, can also apply to specific topics covered in this document.

Edition2022
Published Date2022
Published ByISO/TS
Page Count35